Company / Interest Expense
Ernexa Therapeutics Inc. Interest Expense History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$174.0K
FY2025
5-year range
$30.0K / $296.0K
FY2021-FY2025
Trend
-1.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has fluctuated over the past 10 years, ranging from $26,000 in FY2014 to $517,000 in FY2017.
Based on SEC 10-K filings.
$174,000 in FY2025 with a 10-year CAGR of -1.9%.
Increased from $30,000 to $174,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -5.9%
- 10-Year CAGR
- -1.9%
Key checks
Key Insights
- 5-year CAGR of -5.9%, indicating a declining trend.
- In FY2025, interest expense decreased 1.1% year-over-year.
- Peak interest expense was recorded in FY2017.
- Lowest interest expense in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $174.0K | -1.1% |
| FY2024 | $176.0K | +486.7% |
| FY2023 | $30.0K | -87.3% |
| FY2020 | $236.0K | -20.3% |
| FY2019 | $296.0K | -30.4% |
| FY2018 | $425.0K | -17.8% |
| FY2017 | $517.0K | +82.7% |
| FY2016 | $283.0K | +34.8% |
| FY2015 | $210.0K | +707.7% |
| FY2014 | $26.0K | -40.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026